Pfizer Buys Back Former Wyeth Plant | Chemical & Engineering News
Volume 89 Issue 28 | p. 20 | Concentrates
Issue Date: July 11, 2011

Pfizer Buys Back Former Wyeth Plant

Department: Business
Keywords: contract manufacturing

Pfizer has exercised its option to buy back a plant in Rouses Point, N.Y., that Wyeth sold to Akrimax in 2008. Wyeth, which Pfizer acquired in 2009, sold the facility in response to a drop in demand for its menopause treatment Premarin. Akrimax leased the facility to Wyeth, which continued manufacturing Premarin as well as over-the-counter drugs and a range of finished-dose pharmaceuticals for Akrimax. Akrimax had hoped to launch a contract manufacturing business at the site but failed to secure enough contracts to make the venture feasible. Last year, Merck & Co. bought back a plant in Riverside, Pa., from PRWT Services under similar circumstances (C&EN, Aug. 16, 2010, page 24).

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment